- Home
- HSCS
as of 09-15-2026 3:50pm EST
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOUTHLAKE |
| Market Cap: | 15.8M | IPO Year: | 2022 |
| Target Price: | $8.00 | AVG Volume (30 days): | 136.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | semi-annual |
| EPS: | -2.10 | EPS Growth: | 50.84 |
| 52 Week Low/High: | $1.63 - $4.35 | Next Earning Date: | 03-16-2026 |
| Revenue: | $4,319 | Revenue Growth: | -0.71% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -1.61 | Index: | N/A |
| Free Cash Flow: | -7430261.0 | FCF Growth: | N/A |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Jul 29, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLJul 29, 2026 · 100% conf.
1D
-1.57%
$2.13
Act: -3.70%
5D
-14.06%
$1.86
Act: +5.56%
20D
-12.11%
$1.90
Transcript text not available. View on SEC.gov →
2025 Q4 Q4 2025 Earnings
8-K Mar 16, 2026
Q4 2025 Earnings
8-KMar 16, 2026
2025 Q3 Q3 2025 Earnings
8-K Dec 15, 2025
Q3 2025 Earnings
8-KDec 15, 2025
Compare HSCS vs Leading Stocks
See how HSCS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HSCS Heart Test Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.